论文部分内容阅读
抗胃癌生物导向药物(IgY-RicinA)是一种新型抗胃癌药物,为进一步给临床使用提供依据,我们对其进行了病理组织学试验研究,现报告如下:试验材料动物为 wistar 大鼠,体重110—150g。
IgY-RicinA is a novel anti-cancer drug that provides a basis for further clinical use. We conducted a histopathological study on it, and the report is as follows: The test material is wistar rat, weight 110-150g.